Clinicopathologic Significance of High Signal Intensity on Diffusion-weighted MR Imaging in the Ureter, Urethra, Prostate and Bone of Patients with Bladder Cancer

Academic Radiology

Volumn 19, Issue 7, 2012, Pages 827-833

  Takeuchi, Mitsuru ^a   Suzuki, Tomohiro ^a   Sasaki, Shigeru ^a   Ito, Masato ^a   Hamamoto, Shuzo ^a   Kawai, Noriyasu ^a   Kohri, Kenjiro ^a   Hara, Masaki ^a   Shibamoto, Yuta ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Bladder cancer; Cancer staging; Diffusion magnetic resonance imaging

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BONE; BONE LESION; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KIDNEY PELVIS CANCER; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATITIS; URETER; URETER CANCER; URETER STONE; URETHRA; URETHRA CANCER;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; ILIUM; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS, MULTIPLE PRIMARY; PROSTATE; PROSTATIC NEOPLASMS; SACRUM; URETER; URETERAL NEOPLASMS; URETHRA; URETHRAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 84862827332     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2012.01.013     Document Type: Article

References (29)

1. Nishie A., Tajima T., Ishigami K., et al. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)-enhanced MRI: added value of diffusion-weighted imaging (DWI). J Magn Reson Imaging 2010, 31:373-382.
2. Yabuuchi H., Matsuo Y., Sunami S., et al. Detection of non-palpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imaging. Eur Radiol 2011, 21:11-17.
3. Tan C.H., Wang J., Kundra V. Diffusion weighted imaging in prostate cancer. Eur Radiol 2011, 21:593-603.
4. Inada Y., Matsuki M., Nakai G., et al. Body diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging?. Eur J Radiol 2009, 70:122-127.
5. Shinya S., Sasaki T., Nakagawa Y., et al. The efficacy of diffusion-weighted imaging for the detection of colorectal cancer. Hepatogastroenterology 2009, 56:128-132.
6. Takenaka D., Ohno Y., Matsumoto K., et al. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging 2009, 30:298-308.
7. Takeuchi M., Sasaki S., Ito M., et al. Urinary bladder cancer: diffusion-weighted MR imaging-accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009, 251:112-121.
8. Matsuki M., Inada Y., Tatsugami F., et al. Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol 2007, 17:201-204.
9. Watanabe H., Kanematsu M., Kondo H., et al. Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value?. AJR Am J Roentgenol 2009, 192:1361-1366.
10. Kim J.H., Kim J.K., Park B.W., et al. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region. J Magn Reson Imaging 2008, 28:1173-1179.
11. Goldman S.M., Fajardo A.A., Naraval R.C., et al. Metastatic transitional cell carcinoma from the bladder: radiographic manifestations. AJR Am J Roentgenol 1979, 132:419-425.
12. Yoshida S., Koga F., Kawakami S., et al. Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology 2010, 75:387-391.
13. Nishizawa S., Imai S., Okaneya T., et al. Diffusion weighted imaging in the detection of upper urinary tract urothelial tumors. Int Braz J Urol 2010, 36:18-28.
14. Takeuchi M., Matsuzaki K., Kubo H., et al. Diffusion-weighted magnetic resonance imaging of urinary epithelial cancer with upper urinary tract obstruction: preliminary results. Acta Radiol 2008, 49:1195-1199.
15. Silvera S., Oppenheim C., Touze E., et al. Spontaneous intracerebral hematoma on diffusion-weighted images: influence of T2-shine-through and T2-blackout effects. AJNR Am J Neuroradiol 2005, 26:236-241.
16. Vikram R., Sandler C.M., Ng C.S. Imaging and staging of transitional cell carcinoma: part 1, lower urinary tract. AJR Am J Roentgenol 2009, 192:1481-1487.
17. Van Poppel H., Sorgeloose T. Radical cystectomy with or without urethrectomy?. Crit Rev Oncol Hematol 2003, 47:141-145.
18. Lim H.K., Kim J.K., Kim K.A., et al. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection-a multireader study. Radiology 2009, 250:145-151.
19. Lamm D.L., Stogdill V.D., Stogdill B.J., et al. Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer. J Urol 1986, 135:272-274.
20. Lim J., Yu J.S., Hong S.W., et al. A case of mass-forming splenic tuberculosis: MRI findings with emphasis of diffusion-weighted imaging characteristics. J Korean Med Sci 2011, 26:457-460.
21. Knap M.M., Lundbeck F., Overgaard J. Prognostic factors, pattern of recurrence and survival in a Danish bladder cancer cohort treated with radical cystectomy. Acta Oncol 2003, 42:160-168.
22. del Regato J.A. Pathways of metastatic spread of malignant tumors. Semin Oncol 1977, 4:33-38.
23. Nakanishi K., Kobayashi M., Nakaguchi K., et al. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. Magn Reson Med Sci 2007, 6:147-155.
24. Yasumoto M., Nonomura Y., Yoshimura R., et al. MR detection of iliac bone marrow involvement by malignant lymphoma with various MR sequences including diffusion-weighted echo-planar imaging. Skeletal Radiol 2002, 31:263-269.
25. Tsushima Y., Takahashi-Taketomi A., Endo K. Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T. J Magn Reson Imaging 2009, 30:249-255.
26. Vandecaveye V., De Keyzer F., Vander Poorten V., et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009, 251:134-146.
27. Ren J., Huan Y., Wang H., et al. Diffusion-weighted imaging in normal prostate and differential diagnosis of prostate diseases. Abdom Imaging 2008, 33:724-728.
28. Miller F.H., Hammond N., Siddiqi A.J., et al. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging 2010, 32:138-147.
29. Srinivasan A., Dvorak R., Perni K., et al. Differentiation of benign and malignant pathology in the head and neck using 3T apparent diffusion coefficient values: early experience. AJNR Am J Neuroradiol 2008, 29:40-44.